TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10481	Companies
220813	Keywords
150157	Articles
116811	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 03/26/2026 at 17:45, 2 months 6 days ago

Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed

World Vaccine Congress Vaccine Transgene TG4050 Individualized Neoantigen
BRIEF

published on 01/23/2026 at 08:05, 4 months 9 days ago

Transgene strengthens its scientific committee with two immunotherapy experts.

Immunotherapy Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 01/23/2026 at 08:05, 4 months 9 days ago

Transgene Enhances Scientific Advisory Board with New Appointments

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE

published on 01/23/2026 at 08:00, 4 months 9 days ago

Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 11/27/2025 at 00:20, 6 months 4 days ago

Transgene: Resumption of Trading on Euronext Paris

Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE

published on 11/27/2025 at 00:15, 6 months 4 days ago

Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
Transgene resumes trading of shares on Euronext Paris following capital increase results publication

Euronext Paris Shares Trading Capital Increase Transgene
BRIEF

published on 11/26/2025 at 23:37, 6 months 4 days ago

Transgene Raises €105 Million for Cancer Vaccine Development

Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE

published on 11/26/2025 at 23:32, 6 months 4 days ago

Transgene Successfully Completes a Fundraising of c. €105 Million
Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028

Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF

published on 11/25/2025 at 22:06, 6 months 6 days ago

Transgene raises funds with the Talisman project

Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF

published on 11/25/2025 at 21:47, 6 months 6 days ago

Temporary suspension of trading in Transgene shares

Euronext Paris Biotechnology Capital Increase Transgene Quoting

Accesswire

Published on 06/01/2026 at 22:01, 24 minutes ago

Unusual Machines Promotes Trish Ellis to Vice President of Human Resources
Published on 06/01/2026 at 21:25, 1 hour ago

China Is Closing the Door on Heavy Rare Earth Exports for Good, NioCorp CEO Warns in Fox News Op-Ed
Published on 06/01/2026 at 18:30, 3 hours 55 minutes ago

Galaxy Ventures Inc. Enters into Definitive Agreement with TruSilver Metals Corp. to Complete Qualifying Transaction
Published on 06/01/2026 at 15:30, 6 hours 55 minutes ago

Karbon-X to Present at the Small Cap Growth Virtual Investor Conference June 4th
Published on 06/01/2026 at 14:30, 7 hours 55 minutes ago

Klondike Gold Announces Receipt of Funds from Gold Royalty Payments and Warrants Exercise

View all ACCESSWIRE

EQS Group

Published on 06/01/2026 at 22:05, 20 minutes ago

EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Published on 06/01/2026 at 22:05, 20 minutes ago

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Published on 06/01/2026 at 21:20, 1 hour 5 minutes ago

Eurobattery Minerals: Loft Capital exercises conversion rights – Conversion Threshold Date reached and a total of 23,798,419 new shares to be registered
Published on 06/01/2026 at 19:00, 3 hours 25 minutes ago

Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs
Published on 06/01/2026 at 17:50, 4 hours 35 minutes ago

Alta Group announcement on Voluntary Takeover Offers for Addiko Bank AG

Les Echos

Published on 06/01/2026 at 18:47, 3 hours 38 minutes ago

Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 4 hours 25 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 4 hours 31 minutes ago

Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 4 hours 31 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 4 hours 40 minutes ago

ENGIE secures €1 billion export financing backed by Euler Hermes

View all LES ECHOS COMFI WIRE